The pharmaceutical industry was able to further increase its sales in the last quarter. The biggest players in the sector are relying on acquisitions and innovations – including the increased use of AI. However, things could get more uncomfortable for pharmaceutical companies in the US market: the future US Secretary of Health and Human Services, Rober F. Kennedy Jr., is considered a critic of the industry and has already spoken out in favor of capping drug prices.
THIS AUTHOR'S POSTS
Eastern Europe: Economies expected to outperform Euro Area
Weakening growth in the eurozone has been an issue on the markets for some time now. In the Central and Eastern European countries, however, this is largely a non-issue. According to forecasts, the region is also likely to grow faster than the eurozone this year. Private consumption in particular has recently proved to be a growth driver. However, the tense situation in German industry is causing concern.
Economic outlook: soft landing with risks attached
On the stock markets, the focus is shifting back to the downside risks. Nevertheless, there are still hopes that inflation will gradually fall and that there will be no recession. But how realistic are the hopes for this “soft landing” of the economy and how can investors position themselves in the current environment?
US tech stocks: Mixed feelings after earnings figures
The shares of the major US technology companies, which had performed very well for a long time, have also fallen recently. The latest half-year figures left the market with mixed feelings: although the figures were largely as expected, there were hardly any increases in profit expectations. Nevertheless, the outlook remains positive, which for fund manager Bernhard Ruttenstorfer has several reasons.
Microfinance: A journey through emerging Kenya
Kenya is one of the largest economies in sub-Saharan Africa and is currently the most heavily weighted country on the African continent in the ERSTE RESPONSIBLE MICROFINANCE fund. Fund manager Martin Cech therefore recently visited the country and a number of companies and microcredit borrowers.
Interview: Minimizing climate risks effectively
Companies have to deal intensively with the risks and opportunities that the climate crisis brings for their business model. These factors therefore also play a major role in our investment process. Stefanie Schock, Senior Research Analyst in our Responsible Investments team, explains how this works for the ERSTE WWF STOCK ENVIRONMENT equity fund.
Cleantech stocks: low valuations as opportunity?
Shares from the environmental sector have recently been less in the market’s favor. However, the expansion of renewable energies is continuing at a rapid pace and the AI boom could significantly boost demand for green electricity. Given the good growth prospects and the cheap valuation level, green stocks could currently be worth a look. Alexander Weiss, co-fund manager of the environmental equity funds ERSTE WWF STOCK ENVIRONEMNT and ERSTE GREEN INVEST, explains the background in an interview.
ERSTE OPPORTUNITIES MIX: the most important questions and answers
Taking advantage of short- and medium-term opportunities on the markets while at the same time focusing on long-term future trends – the new mixed fund ERSTE OPPORTUNITIES MIX makes this possible. We have summarized the most important questions and answers on the launch of the new fund.
Short-term opportunities or long-term trends – why not both?
Investing in the major trends of the future while taking advantage of short-term market opportunities – the new mixed fund ERSTE OPPORTUNITIES MIX makes this possible. Alexander Lechner, Head of Multi Asset Management, explains the concept behind the fund in an interview.
At the pulse of opportunity – new mixed fund about to launch!
Combining long-term trend themes with short and medium-term market opportunities: The new broadly diversified mixed fund ERSTE OPPORTUNITIES MIX makes this possible with its active and flexible approach.